IRCT20200106046021N1招募中3 期
The effect of Quadruple Therapy with Saccharomyces Boulardii or a Lactobacillus Reuteri Strain DSMZ 17648 Supplement (PYLOSHOT®) on Eradication of Helicobacter Pylori and Treatment Side Effects: a Double-Blind Placebo-Controlled Randomized Clinical Trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 no limit（—）
- 性别
- All
入选标准
- •Symptoms of H. pylori-positive as Confirmed by Clinical, Endoscopic, and Pathological Reports.
排除标准
- •Pregnancy and lactation
- •Patients with Liver, CardioPulmonary, Renal, Neoplastic Diseases
- •People taking Proton Pump Inhibitors, Bismuth Salts, or Probiotics for the past 4 weeks and any Immuno Suppressive Drugs
- •Surgery such as Gastrectomy or Gastric Bypass
- •The existence of Autoimmune Diseases
- •IBD (Inflammatory Bowel Disease)
- •Organ Transplant
- •Weight loss over 3kg over the past three months
- •Previous History of Helicobacter Pylori Eradication
- •Oral Antibiotic use in less than 3 months
- •Alcohol abuse
- •Participate in Other Clinical Trials Concurrently
研究者
相似试验
已完成
3 期
Outcome of Saccharomyces boulardii prophlaxis on necrotizing enterocolitisecrotizing eneterocolitis, neonatal sepsis.Necrotizing enterocolitis of fetus and newborn, bacterial sepsis of newbornP77, P36IRCT2012071410279N1Health Ministry Drug and Pharmacy General Management208
招募中
3 期
The effect of Saccharomyces Cerevisiae enriched with selenium and mineral selenium on postpartum depression and sexual satisfactioIRCT20110606006709N23Tabriz University of Medical Sciences108
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysMedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infectionsHelicobacter pylori infectionEUCTR2007-006280-78-IEAxcan Pharma Inc.400
已完成
3 期
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysGastric complaintsHelicobacter infection1001796610004018NL-OMON32065Axcan Pharma16
进行中（未招募）
1 期
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysHelicobacter pylori infectionEUCTR2007-006280-78-FRAxcan Pharma Inc.400